The Management of Malignant Melanoma Revisited

Acta Chirurgica Belgica

Volumn , Issue 5, 1997, Pages 209-214

  Lejeune, Ferdy J ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Adjuvant treatment; Epidemiology; Isolated limb; Melanoma; Perfusion; Primary melanoma; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; CHILD; GENE THERAPY; HUMAN; IMMUNOTHERAPY; INFANT; LYMPHADENECTOMY; MELANOMA; METHODOLOGY; NEWBORN; PATHOLOGY; REVIEW; SKIN TUMOR;

ADULT; ANTINEOPLASTIC AGENTS; CHILD; GENE THERAPY; HUMANS; IMMUNOTHERAPY; INFANT; INFANT, NEWBORN; LYMPH NODE EXCISION; MELANOMA; SKIN NEOPLASMS;

EID: 0031244109     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Tyrrell Rex M. Ultraviolet Protection. In : "Malignant Melanoma : medical and surgical management". 91-97. Eds. F. Lejeune, P. Chaudhuri, T. Das Gupta, McGraw-Hill, Inc., New-York, 1993.
2. Autier Ph., Doré J.-F., Lejeune F., Koelmel K.F., Geffeler O., Hille P., Cesarini J.P., Liénard D., Liaboeuf A., Joarlette M. et al. Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma. Results of an European Organization for Research and Treatment of Cancer (EORTC) case-control study in Belgium, France and Germayn. The EORTC Malignant Melanoma Cooperative Group. Melanoma Res., 4 : 79-85, 1994.
3. Autier Ph., Doré J.-F, Schifflers E., Cesarini J.-R, Bollaerts A., Koelmel K.F., Geffeler O., Liabeuf A., Lejeune F., Liénard D, et al. Melanoma and use of sunscreens : an EORTC-case-control study in Germany, Belgium and France. The EORTC Malignant Melanoma Cooperative Group. Int J Cancer, 61 : 749-55, 1995.
4. Rhodes Arthur R. "Potential Precursors of Cutaneous Melanoma". In : "Malignant Melanoma : medical and surgical management". 97-127. Eds. F. Lejeune, P. Chaudhuri, T. Das Gupta, McGraw-Hill, Inc., New-York, 1993.
5. McCarthy W.H. and Shaw H.M. "The influence of Prognostic Factors on Melanoma Management". In : "Malignant Melanoma : medical and surgical management". 171-187. Eds. F. Lejeune, P. Chaudhuri, T. Das Gupta, McGrawHill, Inc., New-York, 1993.
6. Conférence de consensus : Suivi des patients opérés d'un mélanome de stade I. Ed. : Agence Nationale pour le Développement de l'évaluation médicale. 30/3/95, Paris, France.
7. Veronesi U., Adamus J., Bandiera D.C., et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extrimities. Cancer, 1982, 49 : 2420-2430.
8. Sim F.H., Taylor W.F., Pritchard D.J., Soule E.H. Lymphadenectomy in the management of stage I malignant melanoma : A prospective randomized study. Mayo Clin Proc, 1986, 61 : 697-705.
9. Thompson J.F., McCarthy W.H., Bosch C.M., O'Brien C J., Quinn M.J., et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res, 1995, 5 : 255-60.
10. Schraffordt Koops H., Kroon B., Lejeune F.J. Management of Local recurrence, satellites and in transit metastases of the limbs with isolation perfusion. In : "Malignant Melanoma : medical and surgical management". 221-233. Eds. F. Lejeune, P. Chaudhuri, T. Das Gupta, McGraw-Hill, Inc., New-York, 1993.
11. Schraffordt Koops H., Vaglini M., Kroon B., Thomson J., Göbl J., Eggermont A, Di Fillipo F. and Lejeune F. Value of prophylactic isolated limb perfusion for stage I high risk malignant melanoma : a randomized phase III trial, (abstract). Melanoma Res, 1997, 7 : S 34
12. Lejeune F.J. High dose recombinant tumour necrosis factor (rTNFalpha) administered by isolation perfusion for advanced tumours of the limbs : a model for biochemotherapy of cancer. Eur J Cancer, 1995, 31A : 1009-16.
13. Leyvraz S., Spataro V., Bauer J., Zografos L., Salmon R., Gillet M., Lejeune F Hepatic arterial chemotherapy for liver metastases from ocular melanoma. Proceedings ASCO Annual Meeting, Philadelphia, May 18-21, 1996. Abstract 1352, p. 435.
14. Kirkwood J., Strawderman M.H., Ernstoff M.S., Smith T.J., Borden E.C., Blum R.H. Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma : the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol, 1996, 14 : 7-17.
15. Karakousis C.P., Goumas W., Rao U., Dnscoll D.I., Axillary node dissection in malignant melanoma Am J Surgery, 1991, 162 : 202-7.
16. Proebstle T.M., Scheibenbogen C., Sterry W., Keilholz U. A phase II study of dacarbazine, cisplatin, interferon-alpha and high-dose interleukin-2 in "poor risk" metastatic melanoma. Eur J Cancer, 1996, 32A : 1530-3.
17. Boon T., van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J Exp Med, 1996, 183 : 725-729.
18. Cerottini J.-C., Liénard D., Romero P. Recognition of tumor-associated antigens by T-lymphocytes . perspectives for peptidebased vaccines. Ann Oncol, 1996, 7 339-342.